Emtricitabine Recruiting Phase 4 Trials for Bone Demineralization Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02322099Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss